GENinCode Plc (GENI.L)
- ACCESSWIRE
CARDIO inCode-Score (CIC-Score) Presentation at the European Society of Cardiology
Preventive Cardiology Congress Athens 2024 OXFORD, ENGLAND / ACCESSWIRE / May 1, 2024 /GENinCode Plc, the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer, gave details of a presentation by Kaiser Permanente ...
- ACCESSWIRE
CARDIO inCode-Score Clinical Publication on Polygenic Risk of Coronary Heart Disease
US Study Publication in the American Journal of Preventive Cardiology OXFORD, UK / ACCESSWIRE / April 5, 2024 / GENinCode Plc ( www.genincode.com ) the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer, announces ...
- ACCESSWIRE
CARDIO inCode Study Results Presented at ESC Annual Meeting
GENinCode Plc (AIM - GENI), the polygenics company focused on the prevention of cardiovascular disease, announced the presentation by Kaiser Permanente on the 'Utility of the CARDIO inCode-Score CHD polygenic risk score for incident coronary heart disease interplay with lifestyle in a multi-ethnic cohort of more than 60,000 individuals.' The presentation was made at the Annual Meeting of the European Society of Cardiologists ("ESC") Congress from
